Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has CE-Marked Mologic Ltd’s (‘Mologic’) lateral flow antibody test for COVID-19 for
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has CE-Marked Mologic Ltd’s (‘Mologic’) lateral flow antibody test for COVID-19 for
VISITECT® CD4 Advanced Disease test receives WHO Prequalification
CE Marking of COVID-19 lateral flow antibody test for professional use
Colin King, CEO of Omega commented: “We are delighted to be part of this consortium and to support the Scottish and UK Governments’ efforts to combat the Coronavirus pandemic and